Disc Medicine, Inc. (IRON) stock
IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
$76.57−0.02 (-0.03%)
Close on Nov 17, 2026Market cap $2.94BP/E –Yield –
Disc Medicine total assets
Total assets on the balance sheet at the end of each period.
Disc Medicine's total assets was $735.07M at Jun 30, 2026. For fiscal 2025 it was $806.88M, up 62.4% from the year before. The highest annual figure on record is $806.88M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $806.88M | +62.4% |
| FY2024 | Dec 31, 2024 | $496.77M | +35.0% |
| FY2023 | Dec 31, 2023 | $368.00M | +83.8% |
| FY2022 | Dec 31, 2022 | $200.21M | +116.6% |
| FY2021 | Dec 31, 2021 | $92.41M | +1010.8% |
| FY2020 | Dec 31, 2020 | $8.32M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $735.07M | +10.5% |
| Q1 FY2026 | Mar 31, 2026 | $750.21M | +5.8% |
| Q4 FY2025 | Dec 31, 2025 | $806.88M | +62.4% |
| Q3 FY2025 | Sep 30, 2025 | $630.46M | +27.3% |
| Q2 FY2025 | Jun 30, 2025 | $665.06M | +30.3% |
| Q1 FY2025 | Mar 31, 2025 | $709.27M | +100.3% |
| Q4 FY2024 | Dec 31, 2024 | $496.77M | +35.0% |
| Q3 FY2024 | Sep 30, 2024 | $495.15M | +31.5% |
| Q2 FY2024 | Jun 30, 2024 | $510.22M | +32.8% |
| Q1 FY2024 | Mar 31, 2024 | $354.18M | +45.3% |
| Q4 FY2023 | Dec 31, 2023 | $368.00M | +83.8% |
| Q3 FY2023 | Sep 30, 2023 | $376.50M | +255.1% |
| Q2 FY2023 | Jun 30, 2023 | $384.17M | +239.0% |
| Q1 FY2023 | Mar 31, 2023 | $243.78M | +96.1% |
| Q4 FY2022 | Dec 31, 2022 | $200.21M | +116.6% |
| Q3 FY2022 | Sep 30, 2022 | $106.03M | -31.8% |
| Q2 FY2022 | Jun 30, 2022 | $113.33M | -34.3% |
| Q1 FY2022 | Mar 31, 2022 | $124.29M | -34.4% |
| Q4 FY2021 | Dec 31, 2021 | $92.41M | +1010.8% |
| Q3 FY2021 | Sep 30, 2021 | $155.54M | +27.1% |
| Q2 FY2021 | Jun 30, 2021 | $172.42M | – |
| Q1 FY2021 | Mar 31, 2021 | $189.38M | – |
| Q4 FY2020 | Dec 31, 2020 | $8.32M | – |
| Q3 FY2020 | Sep 30, 2020 | $122.36M | – |
See a number that looks wrong?